Posts

Showing posts with the label biotech

Should you buy SAVA stock?

Image
  Buying shares of early stage biotech companies is one of the ways that cash-strapped investors can plant the seeds of massive growth. These companies have the potential to be 100x or 1000x the initial investment. What better way than to look into a cure for Alzheimer’s? I got into SAVA (Cassava Biosciences, lead drug simufilam) at $47 when I was reading an article on Seeking Alpha about the promising company. Given my background treating Alzheimer’s patients, I knew I could do my own homework on the data. They have groundbreaking 9 month data on their new Alzheimer's drug, far better than any drug before it. At 9 months, instead of a 4 point decline as is typical in disease progression, it's a 3 point improvement. This 7 point difference is a very big deal for both cognition and ability to live independently. If even results half this good are replicated in a Phase 3 trial, the FDA would approve it easily. For me, seeing the data, the stock is already de-risked. The stock is ...